Peak expiratory flow (PEF) l/min, is an expiratory air rate. The reduction in airflow
speed is of fundamental importance. The lower is the speed, the higher is
pulmonary residual volume, i.e. there is decrease in the interrelations between
alveolar volume and circulatory blood volume. Generally, decrease of the airflow
is an evidence of the following diseases: bronchitis, pneumonias, lung
neoplasms, abscesses.
This
is a physiological test which measures respiratory performance as a function of
time and volume, which therefore incorporates flow (as flow is volume over
time).
Conventionally,
this test is performed in the following manner:
The patient inhales to TLC
The patient then forcefully exhales into
the spirometer nozzle, through their mouth
The patient continues to exhale until full
expiration is achieved (for reliability, the ERS/ATS recommend recording at
least six seconds of the expiratory time
The expiratory volume over time is
graphed, and variables of spirometry are derived from the various features of
that graph
That graph will be familiar to most:
If one were ever for some
reason asked to reproduce this in their exam, three critically importal
elements must be plotted along it, for maximum marks-scoring: the, FVC
FEV1 and PEF.
FVC: Forced Vital
Capacity: "the maximal volume of air exhaled with
maximally forced effort from a maximal inspiration, i.e. vital
capacity performed with a maximally forced expiratory effort". This manoeuvre measures the difference
between TLC and RV, which is VC. It is an "F" VC because it is
forced, to discriminate between this method of measurement from other, more
leisurely and less compelled methods of measuring the VC. A high value here may
be a marker of lung overinflation
FEV1:
Forced Expiratory Volume over 1 second: "the maximal
volume of air exhaled in the first second of a forced expiration from a
position of full inspiration". As a test of respiratory function it
is made more meaningful by its use in a comparison with the FVC:
FEV1/
FVC ratio: This
is the ratio of gas expired over the first second to the total FVC. As such, it
is an indicator of whether or not there is any airflow limitation. If the ratio
is decreased, that means that there is some limitation to the rate of air
egress from the lungs, which typically points to a diagnosis like COPD or
asthma. Exactly
what "decreased" means seems to vary. The GOLD criteria suggest we
use a cut-off of 70%. The ATS instead use the "lower limit of normal"
criteria from the fifth lowest percentile of spirometry data reported by
the Third National Health and Nutrition Examination Survey
(NHANES III). An increased FEV1/FVC ratio is also
possible, and this is usually associated with a restrictive lung disease
pattern.
PEF is "the
highest flow achieved from a maximum forced expiratory manoeuvre started
without hesitation from a position of maximal lung inflation". It
is the peak expiratory flow rate measured in L/s. This parameter can
be derived from the expiratory curve data; being the rate of volume change
per unit time, one would logically expect this to be represented by the
gradient of the expiratory curve.
Alternatively, one could represent the PEF more effectively by reporting flow over time, which would produce a graphic like this one, stolen from the ERS statement on PEF measurement (Quanjer et al, 1997):
The couple of extra parameters
here are the rise time (RT, the time it takes for the flow to get from 10%
to 90% of the peak value), and the dwell time (DT, the time spent at over
90% of peak flow). Together, these metrics have meaning in the scenario of
long-term follow-up, but they are probably somewhat irrelevant in the impatient
world of intensive care medicine, where instant gratification is
all-important. In any case, a discussion of flow-volume curves is
somewhat outside of the scope of this chapter.
A low PEF suggests obstructive
disease, but not necessarily so. It could also represent poor effort. In fact,
a PEF value, when measured sequentially using a crude bedside instrument, is an
excellent indication of whether or not somebody is about to develop the sort of
respiratory muscle weakness that gets you intubated. An excellent example
is the scenario of a Guillain-Barre syndrome patient whom one is
monitoring. González et al (2016) report their
experience, where GBS patients with a peak flow less than 194 ml/s (~41% of
predicted) were inevitably intubated on the following day.
https://www.gla.ac.uk/media/Media_678202_smxx.pdf
Published on 2 May 2024